NCT04111510 2024-11-21
Autologous Tumor Infiltrating Lymphocytes in Patients With Pretreated Metastatic Triple Negative Breast Cancer
Yale University
Phase 2 Completed
Yale University
Iovance Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)